Avcı, O. Et Al. 2023. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study. Journal of Geriatric Oncology , vol.14, no.8 .

Avcı, O., İriağaç, Y., Çavdar, E., Karaboyun, K., Araz, M., Şakalar, T., ... Değerli, E.(2023). PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study. Journal of Geriatric Oncology , vol.14, no.8.

Avcı, Okan Et Al. "PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study," Journal of Geriatric Oncology , vol.14, no.8, 2023

Avcı, Okan Et Al. "PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study." Journal of Geriatric Oncology , vol.14, no.8, 2023

Avcı, O. Et Al. (2023) . "PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study." Journal of Geriatric Oncology , vol.14, no.8.

@article{article, author={Okan Avcı Et Al. }, title={PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study}, journal={Journal of Geriatric Oncology}, year=2023}